Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 FY- Text added to 2013 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
adaptable, Additionalillumigene, analyzing, andNeisseria, antibiotic, areC, biological, bloodborne, brand, budget, centralized, Chlamydia, communication, compliant, conducive, consume, consuming, decentralized, Decision, deferredillumigene, deliverable, depth, EMEA, flexibility, Giardia, goal, illumigene®Bordetella, illumigene®brand, incentivize, inexpensive, infrastructure, isde, Isothermal, lesser, loyalty, makeillumigene, malaria, menu, migration, mitigate, Mycoplasma, Nanosphere, necessarily, negligible, North, ofH, outcome, outpatient, pace, penetration, portable, prenatal, printer, purity, repeat, resale, rest, ROW, shipment, simple, Singapore, solution, span, stable, strictly, switch, theH, threshold, totalC, transitioning, UK, undertaken, upgrading, whooping
Removed:
Abbott, aging, anticipate, aspect, assembled, assumed, autonomously, bidding, billing, BIODESIGN, biotech, broader, buyer, capability, CDC, Chicken, chose, closed, collaboration, collectively, complement, consisting, conversion, convert, core, counter, decline, deductible, difficileand, difficileandH, difficileGDH, difficileproduct, dramatic, ease, EnterohemorrhagicE, exceeding, excise, expired, exploration, exposed, fact, fee, Fever, fifty, fixation, flu, forma, formal, functional, genomic, Headquartered, hedge, hold, immunodiffusion, immunofluorescence, importance, infancy, integration, introduction, July, larger, launched, locally, Lyme, mile, molecularC, OEM, offering, opening, opposite, organic, Overview, particle, partly, pediatric, pending, pharmaceutical, Pox, PremierC, pro, producing, recommended, region, reimburse, replacing, response, RSV, satisfy, segmented, sellillumigene, sense, smaller, Spain, specialty, stabilize, tissue, uniquely, unwilling, Valley
Valuein 2012 FY filing- Value in 2013 FY filing
Original filings
Filing view